Glen Oaks, NYNCT07483294Now EnrollingIRB Ready

Psychosis; Acute Clinical Trial in Glen Oaks, NY

Access cutting-edge psychosis; acute treatment through this clinical trial at a research site in Glen Oaks. Study-provided care at no cost to qualified participants.

Sponsored by Northwell Health

Quick Self-Assessment

See if you qualify for this Glen Oaks location

Preparing your pre-screening questions…

Expert Care in Glen Oaks

Access psychosis; acute specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related psychosis; acute treatment provided free

Apply for This Glen Oaks Location

Check if you qualify for this psychosis; acute clinical trial in Glen Oaks, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Glen Oaks

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Glen Oaks site if eligible
  4. 4Begin participation

About This Psychosis; Acute Study in Glen Oaks

This study plans to collect 120 patients with first-episode psychosis. Participants will receive multimodal MRI scans (naturalistic fMRI, structural, diffusional) and comprehensive clinical assessments at baseline, and subsequently be treated with either risperidone or aripiprazole for 12 weeks. Clinical assessments for psychotic symptoms will be followed multiple times during the treatment until the 12th week. Data analysis will be conducted at the Psychiatric Research Unit of the Zucker Hillside Hospital.

Sponsor: Northwell Health

Who Can Participate

Inclusion Criteria

Diagnosis of a first-episode psychotic disorder including: schizophrenia, schizophreniform disorder, schizoaffective disorder, brief psychotic disorder, psychotic disorder Not Otherwise Specified (NOS), bipolar disorder with psychosis, and major depressive disorder with psychosis;
Current positive symptoms rated \> 3 (moderate) on one or more of the Brief Psychiatric Rating Scale (BPRS) psychosis items: conceptual disorganization, grandiosity, hallucinatory behavior, and unusual thought content;
At early phase of illness as defined by having taken antipsychotic drugs for a cumulative lifetime period of 8 weeks or less;
Age 15 to 40;
Competent to sign informed consent.

Exclusion Criteria

Serious neurological or endocrine disorder or brain trauma;
Any medical condition which requires treatment with a medication with psychotropic effects;
Significant risk of suicidal or homicidal behavior;
Cognitive or language limitations, or any other factor that would preclude subjects providing informed consent;
Contraindications to antipsychotic monotherapy;
Contraindications to MR imaging (e.g. pacemaker);
Pregnancy by self report.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Glen Oaks?

Yes, this clinical trial (NCT07483294) has an active research site in Glen Oaks, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Psychosis; Acute Treatment Options in Glen Oaks, NY

If you're searching for psychosis; acute treatment options in Glen Oaks, NY, this clinical trial (NCT07483294) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Glen Oaks research site is actively enrolling participants for this clinical trial. You'll receive care from experienced psychosis; acute specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all psychosis; acute clinical trials near you to find additional studies recruiting in your area.

More Schizophrenia Trials in Glen Oaks, NY

See all schizophrenia clinical trials recruiting in Glen Oaks — not just this study.

Browse Schizophrenia Trials in Glen Oaks →

Browse More Trials by Condition

Schizophrenia TrialsAll Conditions →

Ready to Join in Glen Oaks?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Glen Oaks, NY